Novexel

Developer of antibacterial and antifungal agents to treat bacterial and fungal infections

placeParis, Ile De France, France calendar_todayFounded 2004 language novexel.com

Investor mix

8 investors on record; lead investors include Atlas Venture, 3i Group, Abingworth, Novo Holdings; 3 have since exited.

Investor typeCountShare
Venture capital450%
Private equity113%
Bank & private debt225%
Other / undisclosed113%
Coming soon